Nerve block may ease debilitating headaches after childbirth epidurals
NCT ID NCT04515901
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This study tests whether a sphenopalatine ganglion block (SPGB) using lidocaine can reduce the severity and duration of post-dural puncture headache (PDPH) in new mothers. PDPH is a severe headache that can occur after an epidural or spinal needle insertion for labor pain relief. The study compares early SPGB (with an option for self-administered repeat blocks) to standard conservative care, aiming to see if a larger trial is feasible.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- lidocaine
- What this could lead to
- If effective, this could offer a non-invasive, safe treatment for severe headaches after epidural or spinal anesthesia in childbirth.
- What could go wrong
- This is a small feasibility study, not a large trial. The treatment may not reduce headache severity or duration, and individual results may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Started
-
Dec 2021
- Finished
-
Nov 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-45 * Confirmed PDPH as per ICHD-3 diagnostic criteria Exclusion Criteria: * American Society of Anesthesiologists (ASA) class 4 and above * History of chronic headaches or migraines requiring prescription medication * Known nasal septal deformity or abnormality * Known allergy to amide anesthetics * Intrathecal catheters * Patients who received EBP on the initial presentation with PDPH who declined a trial of conservative management * Postpartum complication delaying maternal discharge
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postdural puncture headache are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
McMaster University Medical Centre
Hamilton, Ontario, L8S 4K1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.